Cantor Fitzgerald Reiterates Overweight Rating for uniQure (NASDAQ:QURE)
uniQure (NASDAQ:QURE – Get Free Report)‘s stock had its “overweight” rating reiterated by Cantor Fitzgerald in a research note issued on Wednesday, Benzinga reports. They presently have a $28.00 target price on the biotechnology company’s stock. Cantor Fitzgerald’s price target points to a potential upside of 339.56% from the company’s previous close. QURE has been […]
6 Nov 10:22 · The Cerbat Gem